Neuronoff, Inc.
PrivateLast Round
Early Funding
Oct 8, 2025
Total Funding Raised
$11.1M
Company Overview
Neuronoff, Inc. is a medical devices company developing an injectable electrode platform for minimally invasive neuromodulation to treat chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuronoff, Inc. Comparables
Compare Neuronoff, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SPR Therapeutics | 76% | |
| Curonix | 74% | |
| Uro Medical Corporation | 71% | |
Neuronoff, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 8, 2025 | ||||
| Grant | Jan 30, 2025 | ||||
| Grant | Aug 1, 2023 | ||||
| Grant | Oct 31, 2019 |
Neuronoff, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| United States Department of Defense | Grant |
| U.S. Department of Defense | Grant |
| NIH RADx | Grant |
| U.S. Department of War | Grant |
| MedTech Angels | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Announced successful chronic large animal demonstration of IPG-compatible Injectrode platform.
- Jan 30, 2025
Received $5M from NIH RADx, U.S. Department of Defense, and U.S. Department of War.
Neuronoff, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuronoff, Inc.'s valuation, stock price, and market status.